Work

An open-label phase II study of ibrutinib in patients with refractory follicular lymphoma.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.tps8614

Authors: Gilles A. Salles, Ajay K. Gopal, Peter Martin, Robert Marcus, Georg Hess, Pier Luigi Zinzani, Tahamtan Ahmadi, Sen Hong Zhuang, Ronald Levy

Institutions: Hôpital Lyon Sud, Seattle Cancer Care Alliance, University of Washington, Weill Cornell Medicine, King's College Hospital, Johannes Gutenberg University Mainz, University of Bologna, Janssen Research & Development (United States), Stanford Medicine, Stanford University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2523635755

Cites:

Cited by: 4

Related to: 10